SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-054323
Filing Date
2022-09-07
Accepted
2022-09-06 18:33:52
Documents
79
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea165307-6k_mainzbio.htm   iXBRL 6-K 16872
2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA ea165307ex99-1_mainzbio.htm EX-99.1 67901
3 HALF-YEAR FINANCIAL STATEMENTS OF MAINZ BIOMED N.V. FOR THE SIX MONTHS ENDED JUN ea165307ex99-2_mainzbio.htm   iXBRL EX-99.2 552596
4 PRESS RELEASE DATED SEPTEMBER 7, 2022 ea165307ex99-3_mainzbio.htm EX-99.3 63769
  Complete submission text file 0001213900-22-054323.txt   4328868

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mynz-20220630.xsd EX-101.SCH 94945
6 XBRL CALCULATION FILE mynz-20220630_cal.xml EX-101.CAL 36697
7 XBRL DEFINITION FILE mynz-20220630_def.xml EX-101.DEF 211667
8 XBRL LABEL FILE mynz-20220630_lab.xml EX-101.LAB 465136
9 XBRL PRESENTATION FILE mynz-20220630_pre.xml EX-101.PRE 228865
73 EXTRACTED XBRL INSTANCE DOCUMENT ea165307-6k_mainzbio_htm.xml XML 584320
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41010 | Film No.: 221229429
SIC: 2834 Pharmaceutical Preparations